Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation

Blood

Volumn 116, Issue 15, 2010, Pages 2694-2705

  Divito, Sherrie J ^a   Wang, Zhiliang ^a   Shufesky, William J ^a   Liu, Quan ^a,b   Tkacheva, Olga A ^a   Montecalvo, Angela ^a   Erdos, Geza ^a   Larregina, Adriana T ^a   Morelli, Adrian E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL THERAPY; CELL TRANSPLANTATION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DONOR; GENETICS; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KNOCKOUT MOUSE; NUCLEOTIDE SEQUENCE; TRANSGENIC MOUSE; TRANSPLANTATION;

ALLOANTIGEN; PRIMER DNA;

ANIMALS; ANTIGEN PRESENTATION; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; DNA PRIMERS; IMMUNOSUPPRESSION; INJECTIONS, INTRAVENOUS; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77957952606     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-251058     Document Type: Article

References (50)

1. Newton WT, Anderson CB. Planned preimmunization of renal allograft recipients. Surgery. 1973;74(3):430-436.
2. Opelz G, Serger DPS, Mickey MR, Terasaki PI. Effect of blood transfusion on subsequent kidney transplants. Transplant Proc. 1973;5(1):253-259.
3. Salvatierra O, Vicenti F, Amed W. Deliberate donor-specific blood transfusion prior to living related renal transplantation: a new approach. Ann Surg. 1980;192(4):543-552.
4. Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature. 1988;332(6160):161-164.
5. Wood ML, Gottschalk R, Monaco AP. Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions. J Immunol. 1984;132(2):651-655. (Pubitemid 14184113)
6. Fabre J, Morris PJ. The effect of donor strain re-treatment on renal allograft rejection in rats. Transplantation. 1972;14(5):608-617.
7. Brennan DC, Mohanakumar T, Flye MW. Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance: a review of efficacy and mechanisms. Am J Kidney Dis. 1995;26(5):701-715.
8. Persijn CG, Cohen B, Lansbergen Q, van Rood JJ. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation. 1979;28(5):396-401. (Pubitemid 10163744)
9. Soulillou JP, Blandin F, Gunther E, Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation. 1984;38(1):63-67. (Pubitemid 14092466)
10. Niimi M, Roelen DL, Witzke O, van Rood JJ, Claas FHJ, Wood KJ. The importance of H2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions. Transplantation. 2000;69(3):411-417.
11. Quezada SA, Fuller B, Jarvinen LZ, et al. Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood. 2003;102(5):1920-1926.
12. Kishimoto K, Yuan X, Auchincloss H, Sharpe AH, Mandelbrot DA, Sayegh MH. Mechanisms of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor costimulatory molecules, and indirect antigen presentation. J Am Soc Nephrol. 2004;15(9):2423-2428.
13. Fu F, Li Y, Qian S, et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996;62(5):659-665.
14. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997;64(12):1808-1815.
15. Lutz MB, Suri RM, Niimi M, et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol. 2000;30(7):1813-1822. (Pubitemid 30456177)
16. Min WP, Gorczynski R, Huang XY, et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunol. 2000;164(1):161-167.
17. Bonham CA, Peng L, Liang X, et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA-Ig. J Immunol. 2002;169(6):3382-3391.
18. DePaz HA, Oluwole OO, Adeyeri AO, et al. Immature rat myeloid dendritic cells generated in lowdose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival. Transplantation. 2003;75(4):521-528.
19. Lan YY, Wang Z, Raimondi G, et al. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig. J Immunol. 2006;177(9):5868-5877. (Pubitemid 44628800)
20. Emmer PM, van der Vlag J, Adema GJ, Hilbrands LB. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation. 2006;81(10):1451-1459.
21. Zhang X, Li M, Lian D, et al. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clin Immunol. 2008;127(3):313-321.
22. Xu DL, Liu Y, Tan JM, et al. Marked prolongation of murine cardiac allograft survival using recipient immature dendritic cells loaded with donor-derived apoptotic cells. Scand J Immunol. 2004;59(6):536-544.
23. Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol. 2007;178(11):7018-7031.
24. Garovillo M, Ali A, DePaz HA, et al Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant. 2001;1(2):129-137.
25. Mirenda V, Berton I, Read J, et al. Modified dendritic cells coexpressing self and allogeneic major histocompatibility complex molecules: an efficient way to induce indirect pathway regulation. J Am Soc Nephrol. 2004;15(4):987-997. (Pubitemid 38375317)
26. Sato K, Yamashita N, Yamashita N, et al. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity. 2003;18(3):367-379.
27. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7(8):610-621.
28. Morelli AE, Larregina AT, Shufesky WJ, et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine secretion. Blood. 2003;101(2):611-620.
29. Corry RJ, Winn HJ, Russell PS. Primary vascularized allografts of hearts in mice. Transplantation. 1973;16(4):343-350.
30. Tiffany LJ, Garcia-Ojeda PA, Stein KE. Determination of the IgG2a allotype of CXB recombinant inbred mouse strains by a PCR-based method. Immunogenetics. 1999;50(1):71-73.
31. Penna G, Adorini L. 1-α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164(5):2405-2411. (Pubitemid 30115468)
32. Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. 2000;164(9):4443-4451.
33. Zahorchack AF, Kean LS, Tokita D, et al. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. Transplantation. 2007;84(2):196-206.
34. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194(6):769-779. (Pubitemid 32983013)
35. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med. 2002;196(12):1627-1638. (Pubitemid 36026474)
36. Mahnke K, Qia Y, Knop J, Enk AH. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 2003;101(12):4862-4869.
37. Wang Z, Larregina AT, Shufesky WJ, et al. Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant. 2006;6(6):1297-1311.
38. Wang Z, Shufesky WJ, Montecalvo A, Divito SJ, Larregina AT, Morelli AE. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE. 2009;4(3):e4940.
39. Tanriver Y, Ratnasothy K, Bucy RP, Lombardi G, Lechler R. Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival. J Immunol. 2010;184(4):1757-1764.
40. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med. 2006;203(8):1851-1858. (Pubitemid 44188459)
41. Montecalvo A, Shufesky WJ, Beer Stolz D, et al. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol. 2008;180(5):3081-3090.
42. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998;392(6671):86- 89.
43. Young LJ, Wilson NS, Schnorrer P, et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol. 2008;11(11):1244- 1252.
44. Kleindienst P, Brocker T. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol. 2003;170(6):2817-2823.
45. Inaba K, Turley S, Yamaide F, et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibiliy complex class II products of dendritic cells. J Exp Med. 1998;188(11):2163-2173.
46. Allan RS, Waithman J, Bedoui S, et al. Migratory dendritic cells transfer antigen to a lymph noderesident dendritic cell population for efficient CTL priming. Immunity. 2006;25(1):153-162. (Pubitemid 44066832)
47. Wise MP, Bemelman F, Cobbold SP, Waldmann H. Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol. 1998;161(11):5813-5816.
48. Carvalho-Gaspar M, Jones ND, Luo S, Martin L, Brook MO, Wood KJ. Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells. J Immunol. 2008;180(10):6640-6648.
49. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 1994;179(3):865-872.
50. Mandelbrot DA, Furukawa Y, McAdam AJ, et al. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol. 1999;163(7):3753-3757. (Pubitemid 29450898)